Literature DB >> 1693928

Eosinophilic polymyositis induced by tranilast.

S Arase1, S Kato, H Nakanishi, Y Sadamoto, Y Urano, H Kawai, K Takeda.   

Abstract

A 38-year-old man with asthma developed eosinophilic polymyositis following the administration of Tranilast, an antiasthmatic agent. Low grade fever, erythematous rashes on the entire body, dysphagia, blood eosinophilia, elevations of serum creatine phosphokinase and myoglobin levels, and inverted T waves in the electrocardiogram were noted. A muscle biopsy showed focal degeneration of muscle fibers with an infiltrate of eosinophils and lymphocytes. A rechallenge with Tranilast resulted in erythema formation, blood eosinophilia, and elevations of some serum muscle enzymes and myoglobin levels. Tranilast was considered to be the causative agent. This is the first reported case of Tranilast-induced eosinophilic polymyositis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693928     DOI: 10.1111/j.1346-8138.1990.tb01622.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  2 in total

1.  The Effects of Tranilast on Cardiomyopathy in Becker Muscular Dystrophy Requires Profound Cardiac and Neurologic Evaluations.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Intern Med       Date:  2018-02-28       Impact factor: 1.271

2.  Severe Rhabdomyolysis without Systemic Involvement: A Rare Case of Idiopathic Eosinophilic Polymyositis.

Authors:  Ayesha Farooq; Vivek Choksi; Andrew Chu; Dhruti Mankodi; Sameer Shaharyar; Keith O'Brien; Uday Shankar
Journal:  Case Rep Rheumatol       Date:  2015-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.